MedPath

Milrinone for the treatment of raised pressure in the lung vessels in neonates

Phase 3
Conditions
Health Condition 1: P293- Persistent fetal circulation
Registration Number
CTRI/2019/11/021896
Lead Sponsor
JIPMER Puducherry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Infants of all gender with Gestational age >34 weeks and birth weight >=1800g

2. <14 days of age

3.Echocardiographic diagnosis of PPHN

4.Requirement for mechanical ventilation

Exclusion Criteria

1.Major congenital anomalies or syndromes including congenital diaphragmatic hernia

2.Any congenital heart disease

3.Clinically evident bleeding diathesis or platelet count <50,000/cmm

4.Hypotension refractory to usual medical treatment (>=20 mL/kg fluid bolus and >=2 inotropes)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of mechanical ventilationTimepoint: at discharge
Secondary Outcome Measures
NameTimeMethod
eonatal mortality <br/ ><br>Duration of oxygen therapy <br/ ><br>Duration of hospital stay <br/ ><br>Timepoint: 28 days <br/ ><br>at discharge <br/ ><br>at discharge
© Copyright 2025. All Rights Reserved by MedPath